New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy

Acta Biochim Pol. 1996;43(1):196-208.

Abstract

The rationale for a pronucleotide approach based on the use of phosphotriesters which incorporate enzyme-mediated bio-labile protection is discussed in detail. Among the studied bio-labile phosphate protecting groups, the S-acyl-2-thioethyl (SATE) groups appeared the most promising as exemplified in cell culture systems in the case of the pronucleotides of 3'-azido-3'-deoxythymidine, 2',3'-didehydro-3'-deoxythymidine, 2',3'-dideoxyadenosine and acyclovir In vivo implementations of such bis(SATE) pronucleotides have been planned for future animal studies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acyclovir / analogs & derivatives
  • Animals
  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / chemistry
  • Antiviral Agents / metabolism
  • Drug Design
  • Humans
  • Indicators and Reagents
  • Models, Biological
  • Nucleotides / chemical synthesis*
  • Nucleotides / chemistry
  • Nucleotides / metabolism
  • Prodrugs / chemical synthesis*
  • Prodrugs / chemistry
  • Prodrugs / metabolism
  • Structure-Activity Relationship
  • Zidovudine / analogs & derivatives

Substances

  • Antiviral Agents
  • Indicators and Reagents
  • Nucleotides
  • Prodrugs
  • Zidovudine
  • Acyclovir